Tara joined Merck in 2007 after obtaining her PhD in Molecular Virology from the University of Pittsburgh School of Medicine. During her 15 years at Merck, she has developed expertise at various nodes in the life cycle of vaccines. She has supported LVV, subunit, and mRNA vaccines from Discovery to Manufacturing and through patient access. In her current role she has responsibility for the upstream and downstream drug substance process development and tech transfer for Merck’s Vaccine pipeline.
